Trials / Unknown
UnknownNCT03618342
Serum Metabolomics Study of Polycystic Ovary Syndrome
Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography-Mass Spectrometry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,272 (actual)
- Sponsor
- Heilongjiang University of Chinese Medicine · Academic / Other
- Sex
- Female
- Age
- 14 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder, which produces in 5-20% reproductive age women. In this study, a nontargeted metabolomics approach based on ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry will be used to investigate serum metabolic characteristics of PCOS. PCOS women and healthy control will be divided into two distinct groups based on multivariate statistical analysis. The findings of this study will offer a new insight to understand the pathogenesis mechanism, and the discriminating metabolites may provide a prospect for PCOS diagnosis.
Conditions
Timeline
- Start date
- 2018-08-02
- Primary completion
- 2019-08-31
- Completion
- 2020-03-31
- First posted
- 2018-08-07
- Last updated
- 2020-03-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03618342. Inclusion in this directory is not an endorsement.